ClearMetabolic — Cash-pay pricing index export of 138 GLP-1 programme records across 86 providers, holding per-programme headline monthly amount, the plan mechanic behind it (microdose versus standard, first-month teaser versus refill price, multi-month bundle versus month-to-month, membership-plus-medication splits), what the headline includes and excludes (medication, clinician consultation, supplies, shipping, B12, diagnostics, coaching), states served, and a per-programme provider record — with a downloadable CSV export behind the table.. Small independent operation with the broadest prov…
ClearMetabolic — Cash-pay pricing index export of 138 GLP-1 programme records across 86 providers, holding per-programme headline monthly amount, the plan mechanic behind it (microdose versus standard, first-month teaser versus refill price, multi-month bundle versus month-to-month, membership-plus-medication splits), what the headline includes and excludes (medication, clinician consultation, supplies, shipping, B12, diagnostics, coaching), states served, and a per-programme provider record — with a downloadable CSV export behind the table.. Small independent operation with the broadest prov…
ClearMetabolic offers (Alternative, Fundamental) — 138 programme records across 86 providers in the cash-pay index export, including 70 compounded semaglutide programmes (headline range $78-$349/month, median $199, 4.5x low-to-high spread), each row carrying price, plan mechanic, inclusions and exclusions, and states served, plus a per-provider directory record, rankings and local-clinic listings over the same dataset.
Compounded GLP-1 cash-pay market benchmarking with a 4.5x spread quantified across 70 compounded semaglutide programmes; employer and payer GLP-1 benefit design and reference pricing; telehealth competitor pricing-strategy intelligence on teaser, microdose and bundle mechanics; market-entry pricing analysis for new GLP-1 telehealth entrants; consumer affordability tools; and shortlist generation for procurement or benefit teams vetting providers at scale.
The data is with 1 years of history.
Coverage spans US; Health Care Services, Pharmaceuticals; alternative, fundamental; equities.
Not yet on file: Summary & mission · Use cases & buyers · FAQ